Scholarlink

Background <p>Melanoma is an immunogenic malignancy with a high metastatic potential, capable of escaping immune surveillance. Among the mechanisms involved, tumor-derived exosomes have been recognized as potent immune modulators, contributing to immune evasion and tumor progression. In this study, we investigated the effects of exosomes derived from melanoma cells on BALB/c splenocytes, focusing on their impact on cell proliferation, apoptosis, and cell cycle regulation, in light of the pivotal role of splenocytes in immune modulation.</p> Methods <p>Exosomes were isolated from B16-F10 melanoma cell supernatant using ultracentrifugation. Their identity was assessed by scanning electron microscopy (SEM), dynamic light scattering (DLS), and Western blotting for exosomal markers. BALB/c mouse splenocytes were isolated and treated with different concentrations of melanoma-derived exosomes. The optimal exosome concentration was determined based on cell viability assessed by the MTT assay. Then, splenocytes were treated with the selected exosome concentration, and the effects on spleen cells were evaluated by evaluating cell proliferation (MTT assay), apoptosis (Annexin V-FITC/PI staining), and cell cycle phases (DAPI staining) via flow cytometry.</p> Results <p>Firstly, the size, morphology, and exosomal markers of the isolated vesicles were assessed, collectively confirming their identity as exosomes. Then, the optimal exosome concentration was found to be 40&#xa0;µg/mL, and treatment with melanoma-derived exosomes resulted in a dose-dependent inhibition of splenocyte proliferation. Moreover, an arrest in the Sub-G1 cell cycle phase and increased apoptosis rate were also observed in splenocytes exposed to exosomes compared to the control group.</p> Conclusion <p>Exosomes derived from B16-F10 melanoma cells were shown to modulate key functional properties of splenocytes. These immunomodulatory effects suggest that melanoma-derived exosomes may contribute to tumor immune evasion by altering the functional dynamics of immune cell populations, highlighting their potential as therapeutic targets in melanoma.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Immune modulation by melanoma-derived exosomes: suppression of BALB/c mice splenic cell proliferation, induction of apoptosis, and cell cycle arrest

  • 期刊论文

  • 发表日期：

    2025年8月6日

查看全文
  • Zahra Kohan,
  • Jalal Shayegh,
  • Tohid Kazemi,
  • Ehsan Ahmadpour,
  • Shabnam Babaei,
  • Najibeh Shekari

摘要

Background

Melanoma is an immunogenic malignancy with a high metastatic potential, capable of escaping immune surveillance. Among the mechanisms involved, tumor-derived exosomes have been recognized as potent immune modulators, contributing to immune evasion and tumor progression. In this study, we investigated the effects of exosomes derived from melanoma cells on BALB/c splenocytes, focusing on their impact on cell proliferation, apoptosis, and cell cycle regulation, in light of the pivotal role of splenocytes in immune modulation.

Methods

Exosomes were isolated from B16-F10 melanoma cell supernatant using ultracentrifugation. Their identity was assessed by scanning electron microscopy (SEM), dynamic light scattering (DLS), and Western blotting for exosomal markers. BALB/c mouse splenocytes were isolated and treated with different concentrations of melanoma-derived exosomes. The optimal exosome concentration was determined based on cell viability assessed by the MTT assay. Then, splenocytes were treated with the selected exosome concentration, and the effects on spleen cells were evaluated by evaluating cell proliferation (MTT assay), apoptosis (Annexin V-FITC/PI staining), and cell cycle phases (DAPI staining) via flow cytometry.

Results

Firstly, the size, morphology, and exosomal markers of the isolated vesicles were assessed, collectively confirming their identity as exosomes. Then, the optimal exosome concentration was found to be 40 µg/mL, and treatment with melanoma-derived exosomes resulted in a dose-dependent inhibition of splenocyte proliferation. Moreover, an arrest in the Sub-G1 cell cycle phase and increased apoptosis rate were also observed in splenocytes exposed to exosomes compared to the control group.

Conclusion

Exosomes derived from B16-F10 melanoma cells were shown to modulate key functional properties of splenocytes. These immunomodulatory effects suggest that melanoma-derived exosomes may contribute to tumor immune evasion by altering the functional dynamics of immune cell populations, highlighting their potential as therapeutic targets in melanoma.